SWISS pharmaceutical company
Novartis has announced the
US$470 million purchase of US
cancer diagnostics firm Genooptix.
Genoptix has about 500 staff in
its operations which specialise in
diagnosing bone marrow, blood
and lymph node cancers.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 11